Shanghai Haohai Biological Technology Co., Ltd. (FRA:5HB)

Germany flag Germany · Delayed Price · Currency is EUR
2.940
+0.020 (0.68%)
Last updated: Dec 5, 2025, 8:05 AM CET
-8.70%
Market Cap 1.24B
Revenue (ttm) 299.77M
Net Income (ttm) 46.00M
Shares Out n/a
EPS (ttm) 0.20
PE Ratio 27.03
Forward PE n/a
Dividend 0.12 (4.04%)
Ex-Dividend Date Sep 5, 2025
Volume n/a
Average Volume 0
Open 2.940
Previous Close 2.920
Day's Range 2.940 - 2.940
52-Week Range 2.560 - 3.400
Beta n/a
RSI 39.65
Earnings Date Mar 22, 2026

About FRA:5HB

Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in China, Europe, the United States, and internationally. It offers ophthalmology products consist of intraocular lens, medical sodium hyaluronate gel, and lubricant eye drop. The company also offers sodium hyaluronate injection, medical chitosan, medical sodium hyaluronate gel, anti-adhesion, and burn wound related products. In addition, it provides injectors, scalpels, suture needles and other products. Further, ... [Read more]

Industry Pharmaceutical Preparations
Founded 2007
Employees 2,156
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 5HB
Full Company Profile

Financial Performance

In 2024, FRA:5HB's revenue was 2.68 billion, an increase of 1.70% compared to the previous year's 2.63 billion. Earnings were 420.45 million, an increase of 1.04%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.